Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zura Bio Ltd Director's Dealing 2023

May 22, 2023

33996_dirs_2023-05-22_05e8795f-76b8-4fc9-8621-e247e9479147.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zura Bio Ltd (ZURA)
CIK: 0001855644
Period of Report: 2023-05-18

Reporting Person: Howell Michael (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-18 Class A Ordinary Shares A 114395 $0.00 Acquired 114395 Direct

Footnotes

F1: The Reporting Person was granted an award of 114,395 Restricted Share Units ("RSUs") on May 18, 2023 (the "Grant Date"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer.